HSPG2 and malignant colon neoplasm: Previous studies have shown that the classic Wnt3a ligand not only stimulates β-catenin transcriptional activity in colon cancer cells, but also activates PLC, promotes Ca2+ mobilization, and induces Rho kinase and PLC-dependent cell migration [27, 28].